United States · Platforms & data · MarketBeat

Twist Bioscience Q4 Earnings Call Highlights

Published by MarketBeat · United States 22 min ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Twist Bioscience (NASDAQ:TWST) reported 28% revenue growth and positive adjusted EBITDA for its fiscal fourth quarter, as demand for DNA, proteins and data used in AI drug discovery helped drive a 22% increase in full-year sales. The company forecast fiscal 2027 revenue of $550 million to $560 mill

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Peraso appoints Kevin Liu as interim CFO

MarketWatch

The S&P 500 is shrugging off Nvidia’s selloff this week. Here’s what’s keeping the rest of the market afloat.

Investing.com

SpaceX, Tesla merger talks progress, Bloomberg News reports

CNBC

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Stocktwits